Search results
Showing 16 to 18 of 18 results for tisagenlecleucel
This guidance has been updated and replaced by NICE technology appraisal guidance 975.
Hundreds could benefit from life saving blood cancer treatment recommended by NICE
People with a rare and aggressive blood cancer will benefit from a potentially life saving treatment, following NICE’s recommendation of a CAR-T (chimeric antigen receptor T-cell) treatment developed by a British spinout company.
Innovative CAR-T therapy recommended to treat an aggressive form of leukaemia.